CPA
CELG

Capital Planning Advisors’s Celgene Corp CELG Stock Holding History

Capital Planning Advisors’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-7,633
Closed -$681K – 128
2018
Q1 		$681K Buy
7,633
+3,915
+105% +$376K 0.24% 83
2017
Q4 		$388K Sell
3,718
-3,091
-45% -$349K 0.14% 102
2017
Q3 		$993K Buy
6,809
+1,634
+32% +$223K 0.39% 65
2017
Q2 		$672K Buy
5,175
+2,967
+134% +$364K 0.3% 68
2017
Q1 		$275K Buy
+2,208
New +$264K 0.14% 102

Other funds holding CELG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Planning Advisors's CELG Position: Q2 2018 in Review

Capital Planning Advisors sold out of Celgene Corp (CELG) in Q2 2018, closing a stake of 7,633 shares — an estimated $681K sold.

Capital Planning Advisors first reported a position in CELG in Q1 2017 and held it in 5 quarters. The position peaked at $993K in Q3 2017. 1,360 funds tracked by Wall St. Rank hold CELG as of Q2 2018.

  • Capital Planning Advisors reported no remaining Celgene Corp position as of Q2 2018 after selling out during the quarter.
  • Capital Planning Advisors sold 7,633 Celgene Corp shares in Q2 2018, an estimated $681K.
  • Capital Planning Advisors first reported a position in Celgene Corp in Q1 2017 and held it in 5 quarters.
  • Capital Planning Advisors's Celgene Corp position peaked at $993K in Q3 2017.
  • 1,360 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2018.

Based on Capital Planning Advisors's 13F filing for Q2 2018, filed 8 Aug 2018.